If you are filing a Marketing Authorization Application (MAA) in Europe, your dossier must reference the current version of 0478 (updated annually in April). The EDQM frequently revises 0478 to include new dosage forms like orodispersible films and mini-tablets.
To truly leverage why 0478 is better, you need to master its five core analytical tests. european pharmacopoeia ph eur monograph tablets 0478 better
| Test | Ph. Eur. 0478 Requirement | Why it beats older standards | | :--- | :--- | :--- | | Appearance | Visual inspection for cracks, chips, and staining. | No ambiguity – includes specific lighting conditions. | | Uniformity of Mass | 20 tablets weighed individually. Deviation ≤5% for tablets >250mg. | Recognizes very low-dose tablets (<2mg), switching to Content Uniformity automatically. | | Disintegration | Apparatus with basket-rack assembly. Time varies (e.g., 15 min for uncoated). | Includes specific media (water, simulated gastric fluid). No "or equivalent" loopholes. | | Dissolution | Apparatus 1 (basket) or 2 (paddle) at 37°C ± 0.5°C. | Requires stage testing (S1, S2, S3) to reduce OOS (Out of Specification) false failures. | | Friability | Roche friabilator. Maximum loss: 1.0% for uncoated tablets. | Includes a specific clause for tablets that lose weight during dedusting. | If you are filing a Marketing Authorization Application
In the landscape of pharmaceutical regulation, quality standards are not merely technical documents but the bedrock of public health. Among the most influential of these is the European Pharmacopoeia (Ph. Eur.), a legally binding collection of monographs that define the quality of medicines across 38 European member states and beyond. Monograph 0478, titled Tablets, stands as a particularly critical standard. Far from a simple checklist, this monograph provides a comprehensive framework for the quality control of one of the most common and trusted pharmaceutical dosage forms. This essay argues that Ph. Eur. Monograph 0478 establishes a “better” standard for tablets by mandating rigorous, harmonised tests—such as uniformity of mass, disintegration, dissolution, and uniformity of content—which collectively ensure batch-to-batch consistency, therapeutic efficacy, and patient safety. | Test | Ph
The current Ph. Eur. Monograph 0478 is excellent. It has successfully evolved from a rigid, traditional standard into a flexible, science-based framework that accommodates modern pharmaceutical manufacturing technologies (like 3D printing and complex release mechanisms) while harmonizing with global standards (USP/JP).